Owned by L'Oréal, La Roche-Posay has emerged as a leader in microbiome science, environmental protection, and post-procedure skin recovery and is seen as a pioneer in dermocosmetic innovation. 

Since 2008, the organisation has focused on the effects of cancer on the skin – both the diagnosis and the treatments. It recently established a Skin Management in Oncology Group Advisory Group in Australia and New Zealand.

A significant part of La Roche Posay’s partnership is the support of an additional Support Services Coordinator who will champion for all LBC’s support team the awareness of skin side effects and the possible care to improve the patient’s quality of life during their cancer journey.